Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma level monitoring of valproate in refractory status epilepticus
2009-013796-22Phase 4Active
- Sponsor
- Bellvitge University Hospital
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of valproic acid and phenytoin in status epilepticus (SE), sponsored by Bellvitge University Hospital. Primary endpoints: Seizure cessation in refractory status epilepticus and Electroencephalographic treatment response monitoring. Started Aug 2009; status: active.
02
Drugs
valproic acidphenytoin
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on 2009-013796-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013796-22.